Back

The Restoration of Social Defects in Schizophrenic Mice by Plant Exposure

Li, M.; Zhang, X.; Li, M.; Zhou, K.; Liu, S.; Wu, Y.; Li, X.

2024-12-24 neuroscience
10.1101/2024.12.23.630193 bioRxiv
Show abstract

Schizophrenia is a serious psychotic disorder caused by both individuals genetic background and their living environment. However, how the cognitive and negative symptoms can be treated is still a challenge since most anti-psychotic drugs are only effective for positive symptoms. Previous epidemic studies have demonstrated that plant exposure could decrease the risk of schizophrenia and shorten the length of psychiatric hospital admissions for patients. However, it is still unknown whether plant exposure could improve cognition-related defects in schizophrenia, with no related animal studies. In the present study, we first induced a schizophrenia mice model by giving mice long-term (2 weeks) injections of the antagonist of the NMDA receptor: MK801. We then raised the animals in environments containing plants (4 weeks) including Epipremnum aureum and rosemary, and tested their locomotive, anxious and social behaviors. We found that plant exposure did not change the locomotion behaviors of wild-type animals, but significantly reduced the schizophrenia-related social and anxious behaviors in the schizophrenic animals. In addition, we tested the expression of c-Fos in animals exposed to plants after social behavioral testing and found that the deficits in c-Fos expression in both the hippocampus and prefrontal cortex were partially rescued after plant exposure. These results indicate plant exposure will be a new tool to improve the clinical deficits of schizophrenia.

Matching journals

The top 4 journals account for 50% of the predicted probability mass.

1
Schizophrenia Research
29 papers in training set
Top 0.1%
34.4%
2
Progress in Neuro-Psychopharmacology and Biological Psychiatry
36 papers in training set
Top 0.1%
7.1%
3
PLOS ONE
4510 papers in training set
Top 26%
6.6%
4
International Journal of Molecular Sciences
453 papers in training set
Top 2%
4.1%
50% of probability mass above
5
Scientific Reports
3102 papers in training set
Top 29%
4.1%
6
Frontiers in Psychiatry
83 papers in training set
Top 1.0%
3.7%
7
Neuroscience Letters
28 papers in training set
Top 0.3%
2.0%
8
ACS Chemical Neuroscience
60 papers in training set
Top 1%
1.8%
9
Frontiers in Pharmacology
100 papers in training set
Top 2%
1.7%
10
Psychopharmacology
59 papers in training set
Top 0.4%
1.4%
11
European Journal of Neuroscience
168 papers in training set
Top 0.7%
1.3%
12
Schizophrenia
19 papers in training set
Top 0.3%
1.3%
13
Journal of Psychopharmacology
14 papers in training set
Top 0.4%
1.2%
14
Cells
232 papers in training set
Top 4%
1.0%
15
Journal of Neuroscience Research
25 papers in training set
Top 0.3%
1.0%
16
Heliyon
146 papers in training set
Top 4%
1.0%
17
Neuroscience
88 papers in training set
Top 2%
0.8%
18
Biological Psychiatry
119 papers in training set
Top 2%
0.8%
19
Schizophrenia Bulletin
29 papers in training set
Top 0.6%
0.8%
20
Public Health
34 papers in training set
Top 2%
0.8%
21
Molecular Psychiatry
242 papers in training set
Top 3%
0.7%
22
eLife
5422 papers in training set
Top 60%
0.7%
23
Frontiers in Neuroscience
223 papers in training set
Top 8%
0.7%
24
Neuroscience Bulletin
11 papers in training set
Top 0.8%
0.7%
25
Translational Psychiatry
219 papers in training set
Top 4%
0.7%
26
BMC Psychiatry
22 papers in training set
Top 0.9%
0.7%
27
Life Sciences
25 papers in training set
Top 2%
0.5%
28
Neuropsychopharmacology
134 papers in training set
Top 3%
0.5%